Related Experiment Video
Updated: Apr 29, 2026
A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
Subthalamic stimulation improves motor function but not home and neighborhood mobility
Jean-François Daneault1, Christian Duval, Sébastien Barbat-Artigas
1Cone Laboratory for Research in Neurosurgery, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada; Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montréal, Québec, Canada.
Subthalamic nucleus deep brain stimulation (STN DBS) improved Parkinson's disease (PD) motor symptoms but did not significantly enhance life-space mobility or quality of life (QoL) in the intermediate term.
Area of Science:
- Neurology
- Neurosurgery
- Rehabilitation
Background:
- Subthalamic nucleus deep brain stimulation (STN DBS) is a key therapy for Parkinson's disease (PD) motor symptoms.
- The impact of STN DBS on life-space mobility and overall quality of life (QoL) remains less understood.
- Mobility is a crucial aspect of daily functioning and QoL for PD patients.
Purpose of the Study:
- To evaluate the effect of STN DBS on life-space mobility in PD patients.
- To assess the influence of STN DBS on the quality of life (QoL) of individuals with PD.
- To determine the relationship between motor symptom improvement and changes in mobility and QoL post-STN DBS.
Main Methods:
- A cohort of twenty PD patients undergoing STN DBS surgery was studied.
- Patients were evaluated using validated scales for mobility, QoL, and motor function (United Parkinson's Disease Rating Scale).
- Assessments were conducted pre-operatively and at 6 to 9 months post-operatively.
Main Results:
- STN DBS led to significant improvements in motor dysfunction associated with PD.
- However, STN DBS demonstrated a limited impact on measures of life-space mobility.
- Quality of life (QoL) showed only marginal improvements in specific components.
Conclusions:
- While STN DBS effectively addresses motor symptoms in PD, it does not fully translate to enhanced life-space mobility in the intermediate term.
- Improvements in motor function do not automatically guarantee broader mobility or QoL gains.
- A multidisciplinary approach focusing on enhancing mobility, beyond motor symptom management, is recommended to improve long-term QoL for PD patients.
